Causal Effects between Gut Microbiome and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Two-Sample Mendelian Randomization Study.
He, Gang, Cao, Yu, Ma, Honghao et al. · Frontiers in microbiology · 2023 · DOI
Quick Summary
This study used genetic analysis to investigate whether changes in gut bacteria might actually cause ME/CFS, rather than just being associated with it. Researchers found that two types of bacteria—Paraprevotella and Ruminococcaceae_UCG_014—appear to increase the risk of developing ME/CFS. These findings suggest that gut bacteria may play a role in how ME/CFS develops.
Why It Matters
Understanding whether specific gut bacteria actually cause ME/CFS—rather than simply being present in patients—could lead to targeted microbiome-based treatments. This work represents an important step toward identifying modifiable biological mechanisms underlying ME/CFS pathogenesis.
Observed Findings
Genus Paraprevotella showed significant positive association with ME/CFS risk (OR: 1.001, p < 0.05) using the inverse variance weighted method.
Genus Ruminococcaceae_UCG_014 was positively associated with ME/CFS risk (OR: 1.003, p < 0.05) using inverse variance weighted analysis.
Paraprevotella association with ME/CFS was supported by weighted median sensitivity analysis (OR: 1.003, p < 0.05).
211 gut microbiota taxa were analyzed as potential instrumental variables derived from GWAS data.
Inferred Conclusions
A causal relationship exists between elevated levels of Paraprevotella and Ruminococcaceae_UCG_014 and increased ME/CFS risk.
Gut microbiota composition may be an important biological mechanism in ME/CFS development.
These findings support further investigation of microbiota-targeted interventions for ME/CFS prevention or treatment.
Remaining Questions
What are the specific biological or immunological mechanisms by which these bacterial genera contribute to ME/CFS pathogenesis?
Can interventions targeting Paraprevotella or Ruminococcaceae_UCG_014 reduce ME/CFS risk or improve symptoms in affected patients?
Do these causal associations replicate in independent populations and different ethnic/geographic cohorts?
What This Study Does Not Prove
This study does not prove that changing these bacteria will cure or prevent ME/CFS, nor does it establish the mechanisms by which these bacteria might contribute to disease. Mendelian randomization infers causality from genetic associations but cannot definitively prove causal mechanisms in individual patients, and replication in independent cohorts is needed.